Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
SEM Stock Forecast 2026-2027
$16.39
Current Price
$2.03B
Market Cap
Buy 1
Hold 4
Sell 0
Wall St Analyst Ratings
Distance to SEM Price Targets
+3.7%
To High Target of $17.00
+0.7%
To Median Target of $16.50
+0.7%
To Low Target of $16.50
SEM Price Momentum
0.0%
1 Week Change
+0.9%
1 Month Change
+0.2%
1 Year Change
+10.4%
Year-to-Date Change
-11.9%
From 52W High of $18.61
+40.7%
From 52W Low of $11.65
📊 TOP ANALYST CALLS
Did SEM Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Select Medical is one of their latest high-conviction picks.
Latest SEM Stock Price Targets & Analyst Predictions
Based on our analysis of 13 Wall Street analysts, SEM has a neutral consensus with a median price target of $16.50 (ranging from $16.50 to $17.00). The overall analyst rating is Buy (6.8/10). Currently trading at $16.39, the median forecast implies a 0.7% upside. This outlook is supported by 1 Buy, 4 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Ben Hendrix at RBC Capital, suggesting a 0.7% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
SEM Analyst Ratings
1
Buy
4
Hold
0
Sell
SEM Price Target Range
Low
$16.50
Average
$16.50
High
$17.00
Current: $16.39
Latest SEM Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for SEM.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 4, 2026 | Benchmark | Bill Sutherland | Hold | Downgrade | $N/A |
| Mar 3, 2026 | RBC Capital | Ben Hendrix | Sector Perform | Downgrade | $16.50 |
| Feb 23, 2026 | RBC Capital | Ben Hendrix | Outperform | Maintains | $19.00 |
| Oct 8, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $20.00 |
| Sep 10, 2025 | B of A Securities | Joanna Gajuk | Buy | Maintains | $15.00 |
| Aug 4, 2025 | UBS | A.J. Rice | Neutral | Maintains | $14.00 |
| May 7, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $19.00 |
| Feb 24, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $23.00 |
| Jan 3, 2025 | UBS | A.J. Rice | Neutral | Maintains | $21.00 |
| Nov 25, 2024 | Benchmark | Bill Sutherland | Hold | Downgrade | $N/A |
| Nov 4, 2024 | Benchmark | Bill Sutherland | Buy | Reiterates | $48.00 |
| Nov 4, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $47.00 |
| Nov 1, 2024 | Benchmark | Bill Sutherland | Buy | Reiterates | $48.00 |
| Sep 6, 2024 | Benchmark | Bill Sutherland | Buy | Reiterates | $48.00 |
| Aug 20, 2024 | B of A Securities | Joanna Gajuk | Buy | Reinstates | $42.00 |
| Aug 5, 2024 | Benchmark | Bill Sutherland | Buy | Reiterates | $48.00 |
| Aug 2, 2024 | Benchmark | Bill Sutherland | Buy | Reiterates | $48.00 |
| Jul 16, 2024 | Benchmark | Bill Sutherland | Buy | Maintains | $48.00 |
| May 6, 2024 | Benchmark | Bill Sutherland | Buy | Maintains | $42.00 |
| May 6, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $40.00 |
Select Medical Holdings Corp. (SEM) Competitors
The following stocks are similar to Select Medical based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Select Medical Holdings Corp. (SEM) Financial Data
Select Medical Holdings Corp. has a market capitalization of $2.03B with a P/E ratio of 14.1x. The company generates $5.45B in trailing twelve-month revenue with a 2.7% profit margin.
Revenue growth is +2.4% quarter-over-quarter, while maintaining an operating margin of +4.6% and return on equity of +10.6%.
Valuation Metrics
Market Cap
$2.03B
Enterprise Value
$5.20B
P/E Ratio
14.1x
PEG Ratio
-0.1x
Price/Sales
0.4x
Growth & Margins
Revenue Growth (YoY)
+2.4%
Gross Margin
+10.4%
Operating Margin
+4.6%
Net Margin
+2.7%
EPS Growth
-1,239.3%
Financial Health
Cash/Price Ratio
+1.3%
Current Ratio
1.0x
Debt/Equity
140.9x
ROE
+10.6%
ROA
+3.7%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Select Medical Holdings Corp. (SEM) Business Model
About Select Medical Holdings Corp.
What They Do
Operates specialized healthcare facilities in the U.S.
Business Model
The company generates revenue by providing post-acute care services across three segments: Critical Illness Recovery Hospitals, Rehabilitation Hospitals, and Outpatient Rehabilitation Clinics. This model focuses on treating complex medical conditions and delivering personalized rehabilitation services to improve patient outcomes.
Additional Information
Founded in 1996 and based in Mechanicsburg, Pennsylvania, the company emphasizes clinical quality and operational excellence, playing a significant role in the healthcare providers and services sector. Its multidisciplinary teams work to enhance the quality of life for patients requiring specialized recovery and rehabilitation.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
30,800
CEO
Mr. David S. Chernow
Country
United States
IPO Year
2009
Website
www.selectmedical.comSelect Medical Holdings Corp. (SEM) Latest News & Analysis
Latest News
Quick Summary
Kaskela Law LLC is investigating the fairness of Select Medical Holdings Corp.'s proposed buyout at $16.50 per share for shareholders.
Why It Matters
The investigation into the buyout price of Select Medical may indicate potential undervaluation, impacting shareholder sentiment and stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Select Medical Holdings Corporation to Announce First Quarter 2026 Results on Thursday, April 30, 2026
11 days ago
Quick Summary
Select Medical Holdings Corporation (NYSE: SEM) will announce its Q1 2026 financial results on April 30, 2026, after market close.
Why It Matters
Select Medical's upcoming Q1 2026 financial results could impact stock performance, reflecting company health and influencing investor sentiment.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Kaskela Law is investigating the fairness of Select Medical Holdings Corp.'s $16.50 per share buyout offer for shareholders.
Why It Matters
The investigation into Select Medical's buyout price may indicate potential undervaluation, impacting stock price and shareholder sentiment, which could influence investment decisions.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Monteverde & Associates is investigating Select Medical Holdings (NYSE: SEM) regarding its sale to a consortium of executives and directors, following a successful record in class action recoveries.
Why It Matters
The investigation into Select Medical Holdings could signal potential legal issues or financial implications, impacting stock performance and shareholder value.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Kaskela Law LLC is investigating Select Medical Holdings Corp.'s $16.50 per share buyout offer to assess its fairness for shareholders amid concerns it may undervalue the company.
Why It Matters
The investigation into Select Medical's buyout price may indicate potential undervaluation, impacting shareholder sentiment and stock price dynamics.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Brodsky & Smith is investigating Select Medical's Board of Directors for potential fiduciary duty breaches related to the sale of the company for $16.50 per share, totaling $3.9 billion.
Why It Matters
The investigation into Select Medical's Board for potential fiduciary breaches raises concerns about governance and may impact the stock's price and investor confidence amid the acquisition.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About SEM Stock
What is Select Medical Holdings Corp.'s (SEM) stock forecast for 2026?
Based on our analysis of 13 Wall Street analysts, Select Medical Holdings Corp. (SEM) has a median price target of $16.50. The highest price target is $17.00 and the lowest is $16.50.
Is SEM stock a good investment in 2026?
According to current analyst ratings, SEM has 1 Buy ratings, 4 Hold ratings, and 0 Sell ratings. The stock is currently trading at $16.39. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for SEM stock?
Wall Street analysts predict SEM stock could reach $16.50 in the next 12 months. This represents a 0.7% increase from the current price of $16.39. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Select Medical Holdings Corp.'s business model?
The company generates revenue by providing post-acute care services across three segments: Critical Illness Recovery Hospitals, Rehabilitation Hospitals, and Outpatient Rehabilitation Clinics. This model focuses on treating complex medical conditions and delivering personalized rehabilitation services to improve patient outcomes.
What is the highest forecasted price for SEM Select Medical Holdings Corp.?
The highest price target for SEM is $17.00 from at , which represents a 3.7% increase from the current price of $16.39.
What is the lowest forecasted price for SEM Select Medical Holdings Corp.?
The lowest price target for SEM is $16.50 from Ben Hendrix at RBC Capital, which represents a 0.7% increase from the current price of $16.39.
What is the overall SEM consensus from analysts for Select Medical Holdings Corp.?
The overall analyst consensus for SEM is neutral. Out of 13 Wall Street analysts, 1 rate it as Buy, 4 as Hold, and 0 as Sell, with a median price target of $16.50.
How accurate are SEM stock price projections?
Stock price projections, including those for Select Medical Holdings Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 20, 2026 6:08 AM UTC